| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.9 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.0057 | 0.9 |